Constance Longitudinal Imaging of Psychosis Treatment Effects: fMRI

Constance Longitudinal Imaging of Psychosis Treatment Effects: fMRI - CALLIOPE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028050

Enrollment

500

Registered

2022-04-25

Start date

2021-12-20

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F25

Interventions

Group 1: Patients are examined shortly after admission (T1) and shortly before discharge (T2) by means of interview, questionnaires and a behavioral task. In addition, an fMRI or EEG examination will

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: In-patient treatment in a psychosis ward

Exclusion criteria

Exclusion criteria: Insufficient german language proficiency, neurological disorders

Design outcomes

Primary

Measure	Time frame
Treatment outcome using measures of functional level, life satisfaction, and symptom severity.	—

Secondary

Measure	Time frame
Changes in performance as well as neural activity and connectivity.	—

Countries

Germany

Contacts

Public ContactDaniela Mier

Klinische Psychologie, Universität Konstanz

Daniela.Mier@uni-konstanz.de07531-884672

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026